MIA:
- WHO ATC First Level (Anatomical main group) ID: J ANTIINFECTIVES FOR SYSTEMIC USE
- WHO ATC Second Level (Therapeutic subgroup) ID: J04 ANTIMYCOBACTERIALS
- WHO ATC Third Level (Pharmacological subgroup) ID: J04A DRUGS FOR TREATMENT OF TUBERCULOSIS
- WHO ATC Fourth Level (Chemical subgroup) ID: J04AB Antibiotics
- WHO ATC Fifth Level (Chemical substance) ID: J04AB05 Rifapentine
- Chemical Name: Rifapentine
- Chemical Smi: CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C2=O)c2c(O)c(/C=N/N4CCN(CC4)C4CCCC4)c(c(c2c(c3C)O)O)NC(=O)/C(=C\\C=C\\[C@@H]([C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@H]1C)OC(=O)C)C)O)C)O)C)/C
- WHO ICD Mapped Level : A15 A15 Name: Respiratory tuberculosis, bacteriologically and histologically confirmed
- WHO ICD Fourth Level ID: Name:
- WHO ICD Third Level ID: A15 A15 Name: Respiratory tuberculosis, bacteriologically and histologically confirmed
- WHO ICD Second Level ID: A15-A19 A15-A19 Name: Tuberculosis
- WHO ICD First Level ID: I I Name: Certain infectious and parasitic diseases
|
|